
P2 Gold Inc. (TSX-V: PGLD) (OTCQB: PGLDF) reports that under the terms of the convertible debentures issued on March 4, 2024 and March 14, 2024 (see news releases dated March 5, 2024 and March 14, 2024), it has elected to satisfy its obligation to pay accrued interest in shares of the Company.
At June 30, 2025, Convertible Debentures having an aggregate value of $1,189,500 were outstanding (Convertible Debentures having an aggregate value of $475,500 were converted into shares of the Company prior to June 30, 2025). The Company has elected to pay an aggregate of $44,239.65 in interest accrued on the $1,189,500 of Convertible Debentures by issuing to such debenture holders for the interest payment due June 30, 2025 an aggregate of 303,394 common shares of the Company.
The Company will pay to each such debenture holder approximately 255.06 common shares per $1,000 principal amount of Convertible Debentures held as at the applicable interest payment record date. Under the terms of the Convertible Debentures, no fractional common shares will be delivered upon payment of the interest obligation. The issuance of common shares in payment of interest remains subject to the approval of the TSX Venture Exchange. The common shares to be issued in respect of the Interest Payment will be subject to a hold period of four months from the date of issuance.
About P2 Gold Inc.
P2 Gold is a mineral exploration and development company focused on advancing its gold-copper Gabbs Project on the Walker Lane Trend in Nevada. A positive preliminary economic assessment has outlined a long-life, mid-size mine at Gabbs with annual average production of 104,000 ounces gold and 13,500 tonnes copper over a 14.2 year mine life.
Michael Fox interviews Adam Hawkins, President of Global External, about... READ MORE
In this presentation, Jeffrey Christian of CPM Group provides a m... READ MORE
Jeff Clark, senior precious metals analyst shares vital market insights ... READ MORE
Southern Silver Exploration Corp. (TSX-V: SSV) reports that it ha... READ MORE
Michael Fox sits down with Alain Lambert (CEO) and Dr. Craig Gibson (Chi... READ MORE